capecitabine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
capecitabine
Apr 2, 2024, 05:37 |
Drugs
Paolo Tarantino: The OXEL trial is out on Nature Communications
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 27, 2024, 10:07 |
Insight
Piotr Wysocki: No benefit of continuing CDK4/6i beyond progression in advanced ER+/HER2- breast cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 23, 2024, 14:45 |
Insight
Article summaries by Erman Akkus: BMI and cancer prognosis and billiary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter: 1. ''BMI, weight…
Mar 16, 2024, 15:39 |
Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 4, 2024, 17:58 |
Insight
Paolo Tarantino: You don’t always need a fancy new drug to impact patients QoL
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 4, 2024, 10:35 |
Drugs
Yüksel Ürün: Topical diclofenac gel reduces painful hand-foot syndrome in patients on capecitabine
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School…
Feb 1, 2024, 12:41 |
Blog
Mark Lewis: I've heard it said that chemo dosing is the closest a medical oncologist can get to a surgeon's level of precision
Mark Lewis shared a post on X/Twitter: "I've heard it said that chemo dosing is the…
Oct 17, 2023, 01:32 |
Blog
Vivek Subbiah: Awesome poster presentation on Epha2 targeting by our amazing Dr. Elisa Fontana
Vivek Subbiah shared on LinkedIn: "Kudos to our amazing Sarah Cannon Research Institute Phase 1 clinical…
Jul 5, 2023, 05:23 |
Drugs
Cancer drug shortages continue - Stephen V Liu
Cancer drug shortages continue. Carboplatin, cisplatin, capecitabine, methotrexate, azacitadine - the list continues to grow…
All:
9
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube